Download PDF
CC BY-NC-ND 4.0 · J Neuroanaesth Crit Care 2016; 03(02): 083-095
DOI: 10.4103/2348-0548.182344
Review Article
Thieme Medical and Scientific Publishers Private Ltd.

Intensive care management of status epilepticus

Nidhi Gupta
1   Department of Neuroanesthesia, Indraprastha Apollo Hospital, New Delhi, India
› Author Affiliations
Further Information

Publication History

Publication Date:
03 May 2018 (online)

Also available at
   Permissions and Reprints

Abstract

Status epilepticus (SE) is a life-threatening neurological emergency that requires prompt diagnosis and treatment. SE may be classified into convulsive and non-convulsive types, based on the presence of rhythmic jerking of the extremities. Clinically, tonic-clonic convulsive SE (CSE) is divided into four subsequent stages: Early, established, refractory and super-refractory. Initial elements of resuscitation include airway protection, haemodynamic resuscitation and seizure control. Further treatment should then be guided by the diagnostic workup. Rapid treatment of early SE is achieved with intravenous (IV) lorazepam or intramuscular midazolam. In established SE, IV antiepileptic drugs (AEDs) (phenytoin/fosphenytoin, valproate, levetiracetam, phenobarbital) are most commonly used, but there is no Class I evidence for choosing one over the other. Considered overall, cumulative data from the literature are consistent with valproate and levetiracetam, being a safe and effective therapeutic alternative to phenobarbital and phenytoin for treatment of established SE. Refractory SE (RSE) and super-RSE are treated with anaesthetic medications (propofol, midazolam, thiopental/pentobarbital, ketamine), non-anaesthetic drugs (lidocaine, magnesium, pyridoxine), AEDs (levetiracetam, lacosamide, topiramate, lacosamide, pregabalin, gabapentin) and other cause-directed treatments with low success rates. Potential non-pharmacologic interventions to be considered in super-RSE include hypothermia, electroconvulsive therapy, ketogenic diet, immunomodulatory treatments, emergency resective epilepsy surgery, cerebrospinal fluid drainage and vagal nerve or deep brain stimulation or transcranial magnetic stimulation. Diagnosis of non-CSE requires continuous electroencephalography and involves a high index of suspicion in all patients with an altered mental status of unclear cause or with a prolonged postictal state. Treatment options include addressing underlying causes and aggressive pharmacologic interventions with a benzodiazepine, phenytoin and valproate.

Keywords

Antiepileptic drugs - neurointensive care unit - non-convulsive status epilepticus - refractory status epilepticus - status epilepticus - super-refractory status epilepticus
 

  • REFERENCES

  • 1 Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America's Working Group on Status Epilepticus. JAMA 1993; 270: 854-9
    CrossrefPubMedSearch in Google Scholar
  • 2 Jenssen S, Gracely EJ, Sperling MR. How long do most seizures last? A systematic comparison of seizures recorded in the epilepsy monitoring unit. Epilepsia 2006; 47: 1499-503
    CrossrefPubMedSearch in Google Scholar
  • 3 Tomson T. Mortality in epilepsy. J Neurol 2000; 247: 15-21
    CrossrefPubMedSearch in Google Scholar
  • 4 Meierkord H. The risk of epilepsy after status epilepticus in children and adults. Epilepsia 2007; 48 Suppl (Suppl. 08) 94-5
    CrossrefPubMedSearch in Google Scholar
  • 5 Meierkord H, Boon P, Engelsen B, Göcke K, Shorvon S, Tinuper P. et al. EFNS guideline on the management of status epilepticus in adults. Eur J Neurol 2010; 17: 348-55
    CrossrefPubMedSearch in Google Scholar
  • 6 Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T. et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 2012; 17: 3-23
    CrossrefPubMedSearch in Google Scholar
  • 7 Glauser T, Shinnar S, Gloss D, Alldredge B, Arya R, Bainbridge J. et al. Evidence-based guideline: Treatment of convulsive status epilepticus in children and adults: Report of the Guideline Committee of the American Epilepsy Society. Epilepsy Curr 2016; 16: 48-61
    CrossrefPubMedSearch in Google Scholar
  • 8 Mayer SA, Claassen J, Lokin J, Mendelsohn F, Dennis LJ, Fitzsimmons BF. Refractory status epilepticus: Frequency, risk factors, and impact on outcome. Arch Neurol 2002; 59: 205-10
    CrossrefPubMedSearch in Google Scholar
  • 9 Shorvon S, Ferlisi M. The treatment of super-refractory status epilepticus: A critical review of available therapies and a clinical treatment protocol. Brain 2011; 134 (Pt 10) 2802-18
    CrossrefPubMedSearch in Google Scholar
  • 10 Rossetti AO, Hurwitz S, Logroscino G, Bromfield EB. Prognosis of status epilepticus: Role of aetiology, age, and consciousness impairment at presentation. J Neurol Neurosurg Psychiatry 2006; 77: 611-5
    CrossrefPubMedSearch in Google Scholar
  • 11 Sokic DV, Jankovic SM, Vojvodic NM, Ristic AJ. Etiology of a short-term mortality in the group of 750 patients with 920 episodes of status epilepticus within a period of 10 years (1988-1997). Seizure 2009; 18: 215-9
    CrossrefPubMedSearch in Google Scholar
  • 12 Naylor DE, Liu H, Wasterlain CG. Trafficking of GABA (A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus. J Neurosci 2005; 25: 7724-33
    CrossrefPubMedSearch in Google Scholar
  • 13 Sperk G, Wieser R, Widmann R, Singer EA. Kainic acid induced seizures: Changes in somatostatin, substance P and neurotensin. Neuroscience 1986; 17: 1117-26
    CrossrefPubMedSearch in Google Scholar
  • 14 Sloviter RS. Status epilepticus-induced neuronal injury and network reorganization. Epilepsia 1999; 40 Suppl (Suppl. 01) S34-9
    CrossrefPubMedSearch in Google Scholar
  • 15 Silbergleit R, Durkalski V, Lowenstein D, Conwit R, Pancioli A, Palesch Y. et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med 2012; 366: 591-600
    CrossrefPubMedSearch in Google Scholar
  • 16 Brodie MJ, Kwan P. Current position of phenobarbital in epilepsy and its future. Epilepsia 2012; 53 Suppl (Suppl. 08) 40-6
    CrossrefPubMedSearch in Google Scholar
  • 17 Treiman DM, Meyers PD, Walton NY, Collins JF, Colling C, Rowan AJ. et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 1998; 339: 792-8
    CrossrefPubMedSearch in Google Scholar
  • 18 Liu X, Wu Y, Chen Z, Ma M, Su L. A systematic review of randomized controlled trials on the theraputic effect of intravenous sodium valproate in status epilepticus. Int J Neurosci 2012; 122: 277-83
    CrossrefPubMedSearch in Google Scholar
  • 19 Brigo F, Storti M, Del Felice A, Fiaschi A, Bongiovanni LG. IV Valproate in generalized convulsive status epilepticus: A systematic review. Eur J Neurol 2012; 19: 1180-91
    CrossrefPubMedSearch in Google Scholar
  • 20 Velioglu SK, Gazioglu S. Non-convulsive status epilepticus secondary to valproic acid-induced hyperammonemic encephalopathy. Acta Neurol Scand 2007; 116: 128-32
    CrossrefPubMedSearch in Google Scholar
  • 21 Grosse P, Rüsch L, Schmitz B. Pancreatitis complicating treatment with intravenous valproic acid. J Neurol 2002; 249: 484-5
    CrossrefPubMedSearch in Google Scholar
  • 22 Yasiry Z, Shorvon SD. The relative effectiveness of five antiepileptic drugs in treatment of benzodiazepine-resistant convulsive status epilepticus: A meta-analysis of published studies. Seizure 2014; 23: 167-74
    CrossrefPubMedSearch in Google Scholar
  • 23 Misra UK, Kalita J, Maurya PK. Levetiracetam versus lorazepam in status epilepticus: A randomized, open labeled pilot study. J Neurol 2012; 259: 645-8
    CrossrefPubMedSearch in Google Scholar
  • 24 Bleck T, Cock H, Chamberlain J, Cloyd J, Connor J, Elm J. et al. The established status epilepticus trial 2013. Epilepsia 2013; 54 Suppl (Suppl. 06) 89-92
    PubMedSearch in Google Scholar
  • 25 Kim JS, Lee JH, Ryu HW, Lim BC, Hwang H, Chae JH. et al. Effectiveness of intravenous levetiracetam as an adjunctive treatment in pediatric refractory status epilepticus. Pediatr Emerg Care 2014; 30: 525-8
    CrossrefPubMedSearch in Google Scholar
  • 26 Claassen J, Hirsch LJ, Emerson RG, Mayer SA. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: A systematic review. Epilepsia 2002; 43: 146-53
    PubMedSearch in Google Scholar
  • 27 Prabhakar H, Bindra A, Singh GP, Kalaivani M. Propofol versus thiopental sodium for the treatment of refractory status epilepticus (Review). Evid Based Child Health 2013; 8: 1488-508
    CrossrefPubMedSearch in Google Scholar
  • 28 Rossetti AO, Milligan TA, Vulliémoz S, Michaelides C, Bertschi M, Lee JW. A randomized trial for the treatment of refractory status epilepticus. Neurocrit Care 2011; 14: 4-10
    CrossrefPubMedSearch in Google Scholar
  • 29 Gaspard N, Foreman B, Judd LM, Brenton JN, Nathan BR, McCoy BM. et al. Intravenous ketamine for the treatment of refractory status epilepticus: A retrospective multicenter study. Epilepsia 2013; 54: 1498-503
    CrossrefPubMedSearch in Google Scholar
  • 30 Ilvento L, Rosati A, Marini C, L'Erario M, Mirabile L, Guerrini R. Ketamine in refractory convulsive status epilepticus in children avoids endotracheal intubation. Epilepsy Behav 2015; 49: 343-6
    CrossrefPubMedSearch in Google Scholar
  • 31 Ubogu EE, Sagar SM, Lerner AJ, Maddux BN, Suarez JI, Werz MA. Ketamine for refractory status epilepticus: A case of possible ketamine-induced neurotoxicity. Epilepsy Behav 2003; 4: 70-5
    CrossrefPubMedSearch in Google Scholar
  • 32 Hattori H, Yamano T, Hayashi K, Osawa M, Kondo K, Aihara M. et al. Effectiveness of lidocaine infusion for status epilepticus in childhood: A retrospective multi-institutional study in Japan. Brain Dev 2008; 30: 504-12
    CrossrefPubMedSearch in Google Scholar
  • 33 Zeiler FA, Zeiler KJ, Teitelbaum J, Gillman LM, West M, Kazina CJ. Lidocaine for status epilepticus in pediatrics. Can J Neurol Sci 2015; 42: 414-26
    CrossrefPubMedSearch in Google Scholar
  • 34 Zeiler FA, Zeiler KJ, Kazina CJ, Teitelbaum J, Gillman LM, West M. Lidocaine for status epilepticus in adults. Seizure 2015; 31: 41-8
    CrossrefPubMedSearch in Google Scholar
  • 35 Sivakumar S, Ibrahim M, Parker Jr. D, Norris G, Shah A, Mohamed W. Clobazam: An effective add-on therapy in refractory status epilepticus. Epilepsia 2015; 56: e83-9
    CrossrefPubMedSearch in Google Scholar
  • 36 Mirsattari SM, Sharpe MD, Young GB. Treatment of refractory status epilepticus with inhalational anesthetic agents isoflurane and desflurane. Arch Neurol 2004; 61: 1254-9
    PubMedSearch in Google Scholar
  • 37 Sutter R, Marsch S, Fuhr P, Kaplan PW, Rüegg S. Anesthetic drugs in status epilepticus: Risk or rescue?. A 6-year cohort study. Neurology 2014; 82: 656-64
    CrossrefPubMedSearch in Google Scholar
  • 38 Refractory Status Epilepticus Treatment Study. Available from: https://www.clinicaltrials.gov/ct2/show/NCT01586208 [Last Accessed on 2016 Mar 12].
    PubMed
  • 39 Ferlisi M, Shorvon S. The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy. Brain 2012; 135 (Pt 8) 2314-28
    CrossrefPubMedSearch in Google Scholar
  • 40 Visser NA, Braun KP, Leijten FS, van Nieuwenhuizen O, Wokke JH, van den Bergh WM. Magnesium treatment for patients with refractory status epilepticus due to POLG1-mutations. J Neurol 2011; 258: 218-22
    CrossrefPubMedSearch in Google Scholar
  • 41 Yeghiazaryan NS, Zara F, Capovilla G, Brigati G, Falsaperla R, Striano P. Pyridoxine-dependent epilepsy: An under-recognised cause of intractable seizures. J Paediatr Child Health 2012; 48: E113-5
    CrossrefPubMedSearch in Google Scholar
  • 42 Hottinger A, Sutter R, Marsch S, Rüegg S. Topiramate as an adjunctive treatment in patients with refractory status epilepticus: An observational cohort study. CNS Drugs 2012; 26: 761-72
    CrossrefPubMedSearch in Google Scholar
  • 43 Sutter R, Marsch S, Rüegg S. Safety and efficacy of intravenous lacosamide for adjunctive treatment of refractory status epilepticus: A comparative cohort study. CNS Drugs 2013; 27: 321-9
    CrossrefPubMedSearch in Google Scholar
  • 44 Lambrecq V, Villéga F, Marchal C, Michel V, Guehl D, Rotge JY. et al. Refractory status epilepticus: Electroconvulsive therapy as a possible therapeutic strategy. Seizure 2012; 21: 661-4
    CrossrefPubMedSearch in Google Scholar
  • 45 Nam SH, Lee BL, Lee CG, Yu HJ, Joo EY, Lee J. et al. The role of ketogenic diet in the treatment of refractory status epilepticus. Epilepsia 2011; 52: e181-4
    CrossrefPubMedSearch in Google Scholar
  • 46 Corry JJ, Dhar R, Murphy T, Diringer MN. Hypothermia for refractory status epilepticus. Neurocrit Care 2008; 9: 189-97
    CrossrefPubMedSearch in Google Scholar
  • 47 Vezzani A, Ruegg S. Immunity and inflammation in epilepsy: A mechanistic insights and therapeutic perspectives. Epilepsia 2011; 52: 1-53
    PubMedSearch in Google Scholar
  • 48 Winkler PA. Surgical treatment of status epilepticus: A palliative approach. Epilepsia 2013; 54 Suppl (Suppl. 06) 68-71
    CrossrefPubMedSearch in Google Scholar
  • 49 Widjaja E, Li B, Schinkel CD, Puchalski Ritchie L, Weaver J, Snead OC. et al. Cost-effectiveness of pediatric epilepsy surgery compared to medical treatment in children with intractable epilepsy. Epilepsy Res 2011; 94: 61-8
    CrossrefPubMedSearch in Google Scholar
  • 50 Köhrmann M, Huttner HB, Gotthardt D, Nagel S, Berger C, Schwab S. CSF-air-exchange for pharmacorefractory status epilepticus. J Neurol 2006; 253: 1100-1
    CrossrefPubMedSearch in Google Scholar
  • 51 Walker MC. The potential of brain stimulation in status epilepticus. Epilepsia 2011; 52 Suppl (Suppl. 08) 61-3
    CrossrefPubMedSearch in Google Scholar
  • 52 Dunne JW, Summers QA, Stewart-Wynne EG. Non-convulsive status epilepticus: A prospective study in an adult general hospital. Q J Med 1987; 62: 117-26
    PubMedSearch in Google Scholar
  • 53 DeLorenzo RJ, Waterhouse EJ, Towne AR, Boggs JG, Ko D, DeLorenzo GA. et al. Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus. Epilepsia 1998; 39: 833-40
    CrossrefPubMedSearch in Google Scholar
  • 54 Abend NS, Dlugos DJ, Hahn CD, Hirsch LJ, Herman ST. Use of EEG monitoring and management of non-convulsive seizures in critically ill patients: A survey of neurologists 2010; 12: 382-9
    PubMedSearch in Google Scholar
  • 55 Brigo F. Nonconvulsive status epilepticus: The diagnostic dilemma. Neurol India 2013; 61: 3-6
    CrossrefPubMedSearch in Google Scholar
  • 56 Koubeissi MZ, Mayor CL, Estephan B, Rashid S, Azar NJ. Efficacy and safety of intravenous lacosamide in refractory nonconvulsive status epilepticus. Acta Neurol Scand 2011; 123: 142-6
    CrossrefPubMedSearch in Google Scholar
  • 57 Hocker S, Prasad A, Rabinstein AA. Cardiac injury in refractory status epilepticus. Epilepsia 2013; 54: 518-22
    CrossrefPubMedSearch in Google Scholar
  • 58 Stöllberger C, Wegner C, Finsterer J. Seizure-associated takotsubo cardiomyopathy. Epilepsia 2011; 52: e160-7
    CrossrefPubMedSearch in Google Scholar
  • 59 Rizek P, Ikeda KM, Mele T, Garcia B, Gofton TE. Bowel ischemia in refractory status epilepticus: Report of two cases and review of the literature. Neurocrit Care 2016; 24: 128-31
    CrossrefPubMedSearch in Google Scholar
  • 60 Gupta P, Singh VP, Chatterjee S, Agarwal AK. Acute renal failure resulting from rhabdomyolysis following a seizure. Singapore Med J 2010; 51: e79-80
    PubMedSearch in Google Scholar
  • 61 Kowalski RG, Ziai WC, Rees RN, Werner Jr. JK, Kim G, Goodwin H. et al. Third-line antiepileptic therapy and outcome in status epilepticus: The impact of vasopressor use and prolonged mechanical ventilation. Crit Care Med 2012; 40: 2677-84
    CrossrefPubMedSearch in Google Scholar
  • 62 Diedrich DA, Brown DR. Analytic reviews: Propofol infusion syndrome in the ICU. J Intensive Care Med 2011; 26: 59-72
    CrossrefPubMedSearch in Google Scholar
  • 63 Bledsoe KA, Kramer AH. Propylene glycol toxicity complicating use of barbiturate coma. Neurocrit Care 2008; 9: 122-4
    CrossrefPubMedSearch in Google Scholar
  • 64 Fugate JE, Burns JD, Wijdicks EF, Warner DO, Jankowski CJ, Rabinstein AA. Prolonged high-dose isoflurane for refractory status epilepticus: Is it safe?. Anesth Analg 2010; 111: 1520-4
    CrossrefPubMedSearch in Google Scholar